Mandal Shobha, Ponnekanti Sravan K, Dadeboyina Chandrakala, Tipparthi Anusha, Kasireddy Vineela
Internal Medicine, Guthrie Robert Packer Hospital, Sayre, USA.
Internal Medicine, Osmania Medical College, Hyderabad, IND.
Cureus. 2021 Jun 21;13(6):e15791. doi: 10.7759/cureus.15791. eCollection 2021 Jun.
Gallbladder (GB) carcinoma is a rare carcinoma with a poor prognosis. The prevalence is 0.7-21/100,000 worldwide and 1-2/100,000 in the United States. Adenosquamous cell carcinoma is composed of glandular and squamous components. The overall five-year survival rate is less than 5%, with a median survival of fewer than six months. We are presenting a case of adenosquamous carcinoma of the GB in a 76-year-old female who presented with right upper quadrant abdominal pain and was found to have an enlarged GB, with thickened irregular wall likely inflammatory or malignant and mildly dilated common bile duct on ultrasound imaging of the abdomen. Core needle biopsy of GB showed findings compatible with adenosquamous carcinoma and immunohistochemistry was positive for P40, CK5,6. She was diagnosed with stage T4 N0 M0. She was started on chemotherapy with cisplatin and gemcitabine (25 mg/m2 and 1000 mg/m2), respectively, every three weeks but her condition worsened after the fifth cycle of chemotherapy and she decided to move forward with hospice care given her bad prognosis. Unfortunately, she passed away one week after being discharged home.
胆囊癌是一种预后较差的罕见癌症。全球发病率为0.7 - 21/10万,美国为1 - 2/10万。腺鳞癌由腺性和鳞状成分组成。总体五年生存率低于5%,中位生存期不到六个月。我们报告一例76岁女性胆囊腺鳞癌病例,该患者因右上腹疼痛就诊,腹部超声检查发现胆囊增大,壁增厚且不规则,可能为炎症或恶性,胆总管轻度扩张。胆囊粗针活检结果符合腺鳞癌,免疫组化P40、CK5,6呈阳性。她被诊断为T4 N0 M0期。她开始接受化疗,顺铂和吉西他滨分别为每三周25mg/m²和1000mg/m²,但在第五周期化疗后病情恶化,鉴于预后不佳,她决定接受临终关怀。不幸的是,她出院回家一周后去世。